Lisanti Capital Growth, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Lisanti Capital Growth, LLC

  • $344 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$121.19 - $165.49 $1.13 Million - $1.54 Million
-9,285 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$104.21 - $156.44 $420,070 - $630,609
4,031 Added 76.72%
9,285 $1.38 Million
Q1 2020

May 11, 2020
BUY
$93.12 - $133.99 $14,806 - $21,304
159 Added 3.12%
5,254 $572,000
Q4 2019

Feb 13, 2020
BUY
$74.51 - $124.23 $379,628 - $632,951
5,095 New
5,095 $587,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email